FDA
approval
· 2022-11-21
FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
Summary
The FDA approved a supplemental application for Cipla USA Inc. to market generic citalopram. This action confirms the availability of a generic citalopram produ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CITALOPRAM (CITALOPRAM)